

HiFiBiO Therapeutics, a multinational biotechnology company, has secured $75 million in Series D financing. Mirae Asset Financial Group led the round.
Source: Press Release
HiFiBiO Therapeutics, a multinational biotechnology company, has secured $75 million in Series D financing.
HiFiBiO Therapeutics, a multinational biotechnology company, has secured $75 million in Series D financing. Mirae Asset Financial Group led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination